Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an Impella 2.5 percutaneous left ventricular assist device

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 7, 2012, Pages 1129-1134

  Harmon, Laura ^a   Boccalandro, Fernando ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Odessa Heart Institute   (United States)

Author keywords

Acute coronary syndrome; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MITRAL VALVE REGURGITATION; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SEVERE ACUTE ISCHEMIC MITRAL VALVE REGURGITATION; ST SEGMENT ELEVATION; THORAX PAIN;

ACUTE DISEASE; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART-ASSIST DEVICES; HUMANS; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; THROMBECTOMY; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84861960842     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23271     Document Type: Article

References (19)

1. De Souza CF, Brito FD, De Lima VC, Carvalho CDC. Percutaneous mechanical assistance for the failing heart. J Interv Cardiols 2010;23:195-202.
2. Lamas GA, Mitchell GF, Flaker GC, Smith SC, Gersh BJ, Basta L, Mote L, Braunwald E, Pfeffer MA. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation 1997;96:827-833. (Pubitemid 27329616)
3. Kushner FG, Hand M, Smith SC, et al. 2009 Focused updates: ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction (updating 2004 guidelines and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2009;120:2271-2306.
4. Dhar G, Jolly N. Mechanical versus pharmacologic support for cardiogenic shock. Catheter Cardiovasc Interv 2010;75:626-629.
5. Kantrowitz A, Tionneland S, Freed PS. Initial clinical experience with intra-aortic balloon pumping in cardiogenic shock. JAMA 1968;203:135-140.
6. Perera D, Stables R, Thomas M. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: A randomized controlled trial. JAMA 2010;304: 867-874.
7. Remmelink M, Sjauw KD, Henriques JPS, de Winter RJ, Vis MM, Koch KT, Paulus WJ, de Mol BAJM, Tijssen JGP, Piek JJ, Baan J Jr. Effects of mechanical left ventricular unloading by impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients. Catheter Cardiovasc Interv 2010;75:187-194.
8. Dixon SR, Henriques JPS, Mauri L, Sjauw K, Civitello A, Kar B, Loyolka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial). JACC Cardiovasc Inter 2009;2:91-96.
9. Sayer G, Naka Y, Jorde UP. Ventricular assist device therapy. Cardiovasc Ther 2009;27:140-150.
10. Iliodromitis KE, Kahlert P, Plicht B, Hoffmann AC, Eggebrecht H, Erbel R, Konorza TF. High-Risk PCI in acute coronary syndromes with Impella LP 2.5 device support. Int J Cardiol 2010. [Epub ahead of print].
11. Seyfarth M, Sibbing D, Bauer I, Georg F, Bott-Flugel L, Bryne R, Dirschinger J, Kastrati A, Schomig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused my myocardial infarction. JACC 2008;52:1584-1588.
12. ABIOMED Impella 2.5 Insertion Step-by-step. ABIOMED. Danvers, MA. Circulatory Support System Impella LD User manual 2007. Available at: http://www.vadrc.com/opsandifus/Impella/009003.MAA-ImpellaLD-ENG-Rev06.pdf.
13. Voci P, Bilotta F, Caretta Q, Mercanti C, Marino B. Papillary muscle perfusion pattern. A hypothesis for ischemic papillary muscle dysfunction. Circulation 1995;91:1714-1718.
14. Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LSD, van Domburg RT, Serruys PW. Percutaneous left ventricular assist devices versus intra-aortic balloon pump contra-pulsation for treatment of cardiogenic shock: A meta-analysis of controlled trials. Eur Heart J 2009;30:2102-2109.
15. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter MD, Engstrom T, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device. JACC 2009;54:2430-2434.
16. Sauren LDC, Accord RY, Hamzeh K, de Jong M, van der Nagel T, van der Veen FH, Maessen JG. Combined impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: An experimental study. Artif Organs 2007;31:839-843.
17. Gupta A, Allaqaband S, Bajwa T. Combined use of impella device and intra-aortic balloon pump to improve survival in a patient in profound cardiogenic shock post cardiac arrest. Catheter Cardiovasc Interv 2009;74:975-976.
18. Achour H, Boccalandro F, Felli P, Amirian J, Uthman M, Buja M, Smalling RW. Mechanical left ventricular unloading prior to reperfusion reduces infarct size in a canine infarct model. Catheter Cardiovasc Interv 2005;64:182-192. (Pubitemid 40189186)
19. Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2007;28:2057-2063. (Pubitemid 47517433)